IGC Form 8-K Favorable Preliminary Clinical Trial Results - IGC Pharma, INC.

SEC

Filings

December 2, 2021

IGC Form 8-K Favorable Preliminary Clinical Trial Results

Related Posts

8K + XBRL Form 4

September 27, 2024

Richard Prins FORM 144

August 12, 2024

Richard Prins FORM 4

August 12, 2024

CEO Update

Recap of AAIC24 Conference Participation and Poster Presentations

August 28, 2024

Desk of CEO Marijuana Reclass

July 25, 2024